Impact of Incentives and Information on Quality and Utilization in Primary Care 2014, Baseline Survey

Philippines, 2014

Get Microdata

Reference ID

PHL_2014_I3QUIPIE-BL_v01_M

DOI

https://doi.org/10.48529/yv2x-rq07

Producer(s)

Damien B.C.M da Walque, Taejong Kim, John Basa

Collection(s)

The Strategic Impact Evaluation Fund (SIEF) Impact Evaluation Surveys

Metadata

Documentation in PDF DDI/XML JSON

Created on

Feb 03, 2017

Last modified

Jul 10, 2019

Page views

100452

Downloads

24377

Others [spontaneous] (C3_8_Spon)

Data file: E05_noID

Overview

Valid: 23

Invalid: 0

Type: Discrete

Start: 2030

End: 2088

Width: 59

Range: -

Format: character

Questions and instructions

Categories

Value	Cases
ASA, HCT2	1	4.3%
Alpha agonist; clonidine	1	4.3%
Aspirin	9	39.1%
B complex	1	4.3%
Clonidine	1	4.3%
Cloridin (Catapress)	1	4.3%
Cozartan, aspirin	1	4.3%
Diretic/Betablock; Diretic ACE	1	4.3%
Furosemide	1	4.3%
It depends the perfect condition, AGE, Methyldopia-pregnant	1	4.3%
Lifestyle Modification	1	4.3%
Methyldopa, Aldomet for pregnant mother	1	4.3%
Methyldopa-for pregnant mother	1	4.3%
Symvastatin	1	4.3%
Telmisartan	1	4.3%

Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.

Back to Catalog